Mannatech, Incorporated (NASDAQ:MTEX – Get Free Report) Director Larry Jobe bought 2,803 shares of the firm’s stock in a transaction on Wednesday, May 20th. The shares were bought at an average cost of $4.12 per share, with a total value of $11,548.36. Following the purchase, the director directly owned 70,000 shares in the company, valued at approximately $288,400. This trade represents a 4.17% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.
Mannatech Stock Down 1.1%
Mannatech stock opened at $4.37 on Friday. The company has a market capitalization of $8.43 million, a P/E ratio of -0.65 and a beta of 0.61. The firm’s fifty day simple moving average is $5.48 and its 200-day simple moving average is $7.22. The company has a current ratio of 1.09, a quick ratio of 0.59 and a debt-to-equity ratio of 0.48. Mannatech, Incorporated has a 1-year low of $3.80 and a 1-year high of $12.45.
Mannatech (NASDAQ:MTEX – Get Free Report) last released its quarterly earnings results on Thursday, May 14th. The company reported $0.49 earnings per share for the quarter. The business had revenue of $24.92 million for the quarter. Mannatech had a negative net margin of 11.97% and a negative return on equity of 2,383.34%.
Mannatech Company Profile
Mannatech, Inc is a global health and wellness company that develops and markets a range of dietary supplements and personal care products through a direct selling business model. The company’s core focus is on glyconutrients, specialized carbohydrates believed to support cellular communication, which form the basis of many of its flagship offerings. Operating under a network marketing structure, Mannatech empowers independent associates to promote and distribute its products in markets around the world.
The company’s product portfolio includes nutritional supplements aimed at immune support, digestive health, and healthy aging, as well as skincare items designed to promote hydration and skin vitality.
Recommended Stories
- Five stocks we like better than Mannatech
- MarketBeat Week in Review – 05/18 – 05/22
- SpaceX IPO: Opportunity? Or the Ultimate Hype Trade?
- CAVA Group’s Stock Looks Delicious After Strong Earnings
- Lowe’s Finds Support at $215 After Q1 Earnings Sell-Off
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.
